The explosion of new technologies and research techniques, and encouragement from funding agencies for academic institutions to undertake more translational research, has led universities to devote greater resources toward applied drug discovery activity. Universities are now discovering an increasing number of “drug targets” and, as a result, lead companies in the discovery of novel drug targets. This webinar will examine two key problems often encountered by universities and their tech transfer offices in relation to such activities. These problems are: (1) determining whether there is value in filing patents on novel drug targets; and (2) how to progress the development of new drugs against these targets to best position such drugs for licensing to pharma and biotech companies.
Presented by: Lisa Mueller of Casimir Jones and Carole Burns of Johns Hopkins University.
Details coming soon!